Free trial
Subscribe

Log in

(Re)in Asia logo

Emerging risks | Growth Opportunities | APAC Insurance

(Re)in Asia logo
Sunday, October 4, 2026

China Life

china-lifes-ratings-affirmed-as-new-business-value-grows-18-6-in-h1-2024-am-best
China Life's ratings affirmed as new business value grows 18.6% in H1 2024: AM Best
October 1 2024
Fitch Ratings has affirmed China Life’s IFS rating at 'A+' (Strong) and IDR of ‘A’, with the outlook remaining stable despite challenges in investment income. 
A group of people standing in front of an asian building.
Fitch Ratings affirms China Life Insurance's Financial Strength at A+
October 11 2023
Despite observations of potential risks, China Life Insurance's robust performance and substantial government support earn it a continued A+ rating from Fitch.
report-china-life-invests-300-million-yuan-in-series-b-round-for-yingke-biopharmaceutic
Report: China Life invests US $42.4m in Series B round for Yingke Biopharmaceutic
June 5 2023
Yingke was established in 2022 and is engaged in the R&D of pharmaceutical drugs
Photo of two computer screens showing data. China Life logo in top left corner.
China Life's GWP and net profit down in 2022
March 30 2023
GWP and profits were down, but the company increased its investments 7.4% to over 5 trillion Yuan
Banner for 22nd SIRC: 'Capacity to Capability'—Building resilience through innovation; futuristic city skyline with a glowing highway; Nov 1–5, 2026 at Sands Expo & Convention Centre.